Product Data Sheet

Z-VAD-FMK

Catalog No. A12373

main product photo
Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor. Inhibits caspase processing and apoptosis induction in tumor cells in vitro (IC50 = 0.0015 - 5.8 mM). Active in vivo.
Adooq's Z-VAD-FMK has been cited by 35 publications
  • Chantal-Kristin Wenzel, .et al. , Toxicol In Vitro, 2023, Sep;91:105625 PMID: 37268255
  • Joshua H Choe, .et al. , Cancer Discov, 2023, May 4;13(5):1250-1273 PMID: 37067901
  • Yu-Chih Hsu, .et al. , Int J Med Sci, 2023, 20(4): 444-454 PMID: 37057216
  • Debin Qi, .et al. , Cell Cycle, 2023, Apr;22(7):818-828 PMID: 36482709
  • Ming-Chun Hung, .et al. , Cell Biosci, 2022, 12: 122 PMID: 35918763
  • Kaori Kanemaru, .et al. , Nat Commun, 2022, May 9;13(1):2347 PMID: 35534464
  • Chie Ishikawa, .et al. , Invest New Drugs, 2022, Aug;40(4):718-727 PMID: 35477814
  • Aida Falgas, .et al. , Biomed Pharmacother, 2022, Jun;150:112940 PMID: 35421785
  • Sumire Suzuki, .et al. , Oncol Rep, 2022, Feb;47(2):40 PMID: 34958115
  • Lina Y Abou Zeid, .et al. , Cell Stress Chaperones, 2022, Jan;27(1):11-25 PMID: 34719748
  • Simon Boudreault, .et al. , Viruses, 2022, Dec 3;14(12):2710 PMID: 36560714
  • Kosar Jabbari, .et al. , Cancers (Basel), 2021, Sep 8;13(18):4521 PMID: 34572749
  • Xiaoyue Deng, .et al. , Invest Ophthalmol Vis Sci, 2021, May 3;62(6):1 PMID: 33938913
  • Liqun Zhao, .et al. , Apoptosis, 2021, Apr 27 PMID: 33905036
  • Sofia Giacosa, .et al. , Cancers (Basel), 2021, Feb 2;13(3):576 PMID: 33540838
  • Hannes Schmid, .et al. , Haematologica, 2021, Jan 14 PMID: 33440919
  • Hua Xu, .et al. , Cancers (Basel), 2020, Apr; 12(4): 831 PMID: 32235588
  • El-Ashmawy NE, .et al. , Pathol Oncol Res, 2020, Jan 4 PMID: 31902118
  • Schneider D, .et al. , Clin Epigenetics, 2019, Jul 2;11(1):98 PMID: 31266541
  • Fujiki K, .et al. , Cell Death Differ, 2019, Feb 25 PMID: 30804470
  • T Yamamoto, .et al. , Cell Microbiol, 2019, 2019 PMID: 30702185
  • Maeda N, .et al. , J Biol Chem, 2019, Nov 13. pii: jbc.RA119.010379 PMID: 31723031
  • Miyazawa S, .et al. , Breast Cancer, 2019, Oct 17 PMID: 31625014
  • Yeh HT, .et al. , Eur J Pharmacol, 2019, Sep 10;863:172658 PMID: 31518562
  • D. Bosc, .et al. , Sci Rep, 2018, 8: 11653 PMID: 30076329
  • Tsukamoto H, .et al. , J Biol Chem, 2018, Jun 29;293(26):10186-10201 PMID: 29760187
  • Hiroshi Kuribayashi, .et al. , Cell Death Dis, 2018, Sep; 9(9): 891 PMID: 30166529
  • Matsuo J, .et al. , Can J Microbiol, 2018, Oct 18:1-9 PMID: 30336068
  • Orly Ravid, .et al. , Front Cell Neurosci, 2018, 12: 359 PMID: 30459557
  • Im E, .et al. , Life Sci, 2018, Sep 15;209:259-266 PMID: 30107166
  • Szalai P, .et al. , Cell Calcium, 2018, Dec;76:48-61 PMID: 30261424
  • Im E, .et al. , Life Sci, 2018, Jan 1;192:286-292 PMID: 29128513
  • Iriyama N, .et al. , Leuk Lymphoma, 2018, Jun;59(6):1439-1450 PMID: 28918692
  • Birte Plitzko, .et al. , J Biol Chem, 2017, Dec 22; 292(51): 21102-21116 PMID: 29074620
  • Akashi E, .et al. , Oncol Rep, 2017, Jul;38(1):506-514 PMID: 28586026
  • Chemical Information
    Catalog Num A12373
    M. Wt 467.49
    Formula C22H30FN3O7
    Purity >98%
    Storage at -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
    CAS No. 187389-52-2
    Synonyms
    SMILES C[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1
    Storage

    Store lyophilized at -20ºC, keep desiccated.
    In lyophilized form, the chemical is stable for 36 months.
    In solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Biological Activity
    Discription Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor. Inhibits caspase processing and apoptosis induction in tumor cells in vitro (IC50 = 0.0015 - 5.8 mM). Active in vivo.
    Targets
    Target Value
    Solubility
    In vitro (25°C) DMSO 80 mg/mL (171.12 mM)
    Water Insoluble
    Ethanol Insoluble
    In vivo 2% DMSO+35 %PEG 300+2%Tween 80+ddH2O 5 mg/mL
    * <1 mg/ml means slightly soluble or insoluble.
    * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
    Preparing Stock Solutions
    Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
    0.1 mM 21.39 mL 106.95 mL 213.91 mL
    0.5 mM 4.28 mL 21.39 mL 42.78 mL
    1 mM 2.14 mL 10.7 mL 21.39 mL
    5 mM 0.43 mL 2.14 mL 4.28 mL
    RETURN POLICY
    Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
    SHIPPING AND STORAGE
    Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.